We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

GSK Strengthens Vaccines Business with Acquisition of Okairos

News   May 31, 2013

 
GSK Strengthens Vaccines Business with Acquisition of Okairos
 
 
 

RELATED ARTICLES

Zika Vaccine Clinical Trial Begins

News

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine.

READ MORE

Effective Approach to Optimizing Medicinal Molecules Developed

News

Lobachevsky University scientists develop an effective approach to optimizing medicinal molecules, which will significantly accelerate and automate the process of prototype optimization to candidate molecules for subsequent preclinical testing.

READ MORE

Ebola Vaccine Progress and Shortfalls Highlighted

News

Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE